We've recently posted big gains from undervalued stocks. We highlight a beaten-down sector with the potential to deliver even greater profits. Read More

Although options are considered short-term instruments, it's also possible to use them as part of a longer-term strategy. Read More

As stocks hit new highs and risks of a correction get greater, here's how to protect your wealth. Read More

We don't recommend buying stock in Teva Pharmaceutical, but there's a way to profit from Teva even if its share price doesn’t move. Read More

Dr. Stephen Leeb is an investing legend who predicted many trends that the herd never saw coming. Here are his latest insights. Read More

Due to an accounting blunder, NV5 misstated earnings guidance for next year and its stock tanked. Here's how our expert plans to cash in. Read More

The S&P 500 Dividend Aristocrats index shows how stocks with growing dividends can boost total returns over time. Read More

Aramco's massive IPO is scheduled to occur next month. The event raises the question, how can investors properly value a company? Read More

Someone loaded up on NXTC fast. Whoever made the trade may get an unfriendly visit from the SEC. Read More

Amid growing uncertainty, how should you trade? We asked a top expert to provide a roadmap for the future. Read More